These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10903901)

  • 61. Dystroglycan inside and out.
    Henry MD; Campbell KP
    Curr Opin Cell Biol; 1999 Oct; 11(5):602-7. PubMed ID: 10508656
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A synthetic peptide corresponding to the 550-585 region of alpha-dystroglycan binds beta-dystroglycan as revealed by NMR spectroscopy.
    Bozzi M; Veglia G; Paci M; Sciandra F; Giardina B; Brancaccio A
    FEBS Lett; 2001 Jun; 499(3):210-4. PubMed ID: 11423118
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An ischemic beta-dystroglycan (betaDG) degradation product: correlation with irreversible injury in adult rabbit cardiomyocytes.
    Armstrong SC; Latham CA; Ganote CE
    Mol Cell Biochem; 2003 Jan; 242(1-2):71-9. PubMed ID: 12619868
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Agrin binding to alpha-dystroglycan. Domains of agrin necessary to induce acetylcholine receptor clustering are overlapping but not identical to the alpha-dystroglycan-binding region.
    Hopf C; Hoch W
    J Biol Chem; 1996 Mar; 271(9):5231-6. PubMed ID: 8617807
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties.
    Smalheiser NR; Kim E
    J Biol Chem; 1995 Jun; 270(25):15425-33. PubMed ID: 7797531
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue.
    Gesemann M; Brancaccio A; Schumacher B; Ruegg MA
    J Biol Chem; 1998 Jan; 273(1):600-5. PubMed ID: 9417121
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.
    Kunz S; Sevilla N; McGavern DB; Campbell KP; Oldstone MB
    J Cell Biol; 2001 Oct; 155(2):301-10. PubMed ID: 11604425
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface.
    O'Toole JJ; Deyst KA; Bowe MA; Nastuk MA; McKechnie BA; Fallon JR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7369-74. PubMed ID: 8693000
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dystroglycan, Tks5 and Src mediated assembly of podosomes in myoblasts.
    Thompson O; Kleino I; Crimaldi L; Gimona M; Saksela K; Winder SJ
    PLoS One; 2008; 3(11):e3638. PubMed ID: 18982058
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dystrophin-associated proteins and synapse formation: is alpha-dystroglycan the agrin receptor?
    Sealock R; Froehner SC
    Cell; 1994 Jun; 77(5):617-9. PubMed ID: 8205610
    [No Abstract]   [Full Text] [Related]  

  • 71. Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface.
    Herzog C; Has C; Franzke CW; Echtermeyer FG; Schlötzer-Schrehardt U; Kröger S; Gustafsson E; Fässler R; Bruckner-Tuderman L
    J Invest Dermatol; 2004 Jun; 122(6):1372-80. PubMed ID: 15175026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.
    James M; Nuttall A; Ilsley JL; Ottersbach K; Tinsley JM; Sudol M; Winder SJ
    J Cell Sci; 2000 May; 113 ( Pt 10)():1717-26. PubMed ID: 10769203
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interdomain interactions in Grb2 revealed by the conformational stability and CD28 binding analysis.
    Ochi S; Iiyama M; Oda M
    Biophys Chem; 2022 May; 284():106792. PubMed ID: 35276477
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interactions of the rapsyn RING-H2 domain with dystroglycan.
    Bartoli M; Ramarao MK; Cohen JB
    J Biol Chem; 2001 Jul; 276(27):24911-7. PubMed ID: 11342559
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular basis of dystrobrevin interaction with kinesin heavy chain: structural determinants of their binding.
    Ceccarini M; Torreri P; Lombardi DG; Macchia G; Macioce P; Petrucci TC
    J Mol Biol; 2005 Dec; 354(4):872-82. PubMed ID: 16288919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Purification, stabilization, and crystallization of a modular protein: Grb2.
    Guilloteau JP; Fromage N; Ries-Kautt M; Reboul S; Bocquet D; Dubois H; Faucher D; Colonna C; Ducruix A; Becquart J
    Proteins; 1996 May; 25(1):112-9. PubMed ID: 8727323
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sequence analysis suggests the presence of an IG-like domain in the N-terminal region of alpha-dystroglycan which was crystallized after mutation of a protease susceptible site (Arg168-->His).
    Bozic D; Engel J; Brancaccio A
    Matrix Biol; 1998 Nov; 17(7):495-500. PubMed ID: 9881601
    [TBL] [Abstract][Full Text] [Related]  

  • 78. N-terminal alpha-dystroglycan binds to different extracellular matrix molecules expressed in regenerating peripheral nerves in a protein-mediated manner and promotes neurite extension of PC12 cells.
    Hall H; Bozic D; Michel K; Hubbell JA
    Mol Cell Neurosci; 2003 Dec; 24(4):1062-73. PubMed ID: 14697669
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tyrosine phosphorylation as a regulator of dystrophin and beta-dystroglycan interaction: A molecular insight.
    Abdullah M; Hassan A; Rashid S; Naeem M
    J Mol Graph Model; 2020 Sep; 99():107623. PubMed ID: 32348939
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro.
    Bozzi M; Sciandra F; Ferri L; Torreri P; Pavoni E; Petrucci TC; Giardina B; Brancaccio A
    FEBS J; 2006 Nov; 273(21):4929-43. PubMed ID: 17018058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.